Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

pasireotide

EU orphan designation number: EU/3/09/670   
Active ingredient: pasireotide
Indication: Treatment of acromegaly
Sponsor: Novartis Europharm Limited
Frimley Business Park, Camberley GU16 7SR, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2009 Centralised Orphan - Designation EMEA/OD/051/09 (2009)7846 of 08/10/2009
29/08/2014 Centralised Orphan - Change of address